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Abstract 
Differentiation of cerebral tumor pathology currently relies on interpretation of conventional 
structural MRI and in some cases histology. However, more advanced MRI methods may 
provide further insight into the organization of cerebral tumors and have the potential to aid 
diagnosis. The objective of this study was to use multimodal quantitative MRI to measure the 
imaging signatures of meningioma and low-grade glioma (LGG). Nine adults with 
meningioma and 11 with LGG were identified, and underwent standard structural, quantitative 
longitudinal relaxation time (T1) mapping, magnetization transfer and diffusion tensor MRI. 
Maps of mean (D), axial (AX) and radial (RAD) diffusivity, fractional anisotropy (FA), 
magnetization transfer ratio (MTR) and T1 were generated on a voxel-by-voxel basis. Using 
structural and echo-planar T2-weighted MRI, manual region-of-interest segmentation of brain 
tumor, edema, ipsilateral and contralateral normal-appearing white matter (NAWM) was 
performed. Differences in imaging signatures between the different tissue types, both absolute 
mean values and ratios relative to contralateral NAWM, were assessed using t-tests with 
statistical significance set at p < 0.05. For both absolute mean values and ratios relative to 
contralateral NAWM, there were significant differences in D, AX, RAD, FA, MTR and T1 
between meningioma and LGG tumor tissue, respectively. Only T1 and FA differed 
significantly between edematous tissue associated with the two tumor types. These results 
suggest that multimodal MRI biomarkers are significantly different, particularly in tumor 
tissue, between meningioma and LGG. By using quantitative multimodal MRI it may be 
possible to identify tumor pathology non-invasively. 
 
Key words: low-grade glioma; meningioma; magnetic resonance imaging; diffusion; 
magnetization transfer; longitudinal relaxation time 
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1. Introduction 
Cerebral tumors cause neurological symptoms by disturbing the architecture and water content 
of brain tissue (1). Gliomas, either low- (LGG; World Health Organisation (WHO) grades I-II) 
or high-grade (HGG; WHO grades III-IV), are malignant, intrinsic cerebral tumors that may 
cause tumor-infiltrative edema. Meningiomas are mostly benign, extrinsic cerebral tumors that 
do not infiltrate surrounding parenchyma. Mengingiomas may give rise to vasogenic edema in 
the peritumoral tissue (2); however, in both glioma and meningioma, edema is not always 
present. 
In a minority of cases, the radiological diagnosis of cerebral tumors may be insufficient 
on conventional structural imaging, e.g. T2-weighted (T2W) MRI, with or without contrast, 
and confident diagnosis must rely on histopathological analysis (3). Unfortunately, the invasive 
acquisition of tumor biopsy is not without risk. Therefore, the development of reliable 
neuroradiological techniques to predict tumor pathology is required to identify cerebral tumors 
and inform intervention. As a first step towards this goal, a number of studies have identified 
the diffusion tensor MRI (DT-MRI) signatures of HGG and meningiomas (4–6). However, 
there is still a need to report the imaging signatures of other tumor pathologies such as LGG. 
Furthermore, there is a need to investigate whether other imaging modalities, such as 
magnetization transfer MRI (MT-MRI) and quantitative longitudinal relaxation time (T1) 
mapping, can provide useful data to aid tumor characterization. 
DT-MRI is a non-invasive imaging technique that measures the random motion of 
water molecules across the brain due to thermal energy (7). It provides two common 
biomarkers of tissue microstructure, mean diffusivity (D), which measures the magnitude of 
water molecule diffusion, and fractional anisotropy (FA), which measures its directional 
coherence. Low D and high FA values imply good microstructural integrity and organization 
of tissue, especially in cerebral white matter, while high D and low FA values may indicate 
compromised cellular structure (8). Two further biomarkers provided by DT-MRI include the 
axial (AX) and radial (RAD) diffusivities which represent water diffusion parallel and 
perpendicular to the axonal fibers and may be used to infer axonal and/or myelin injury (9). 
MT-MRI provides a further metric of white matter integrity, the magnetization transfer 
ratio (MTR). This parameter measures the efficiency of the magnetization exchange between 
the relatively free water protons inside tissue and those bound to protein macromolecules in 
cellular membranes. Any pathological change in cell membrane macromolecules resulting 
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from loss of tissue structure, such as the presence of edema, will cause a reduction in MTR 
(10).  
T1-mapping may also have use in identifying abnormalities in brain structure caused by 
cerebral neoplasms. This is due to the observation that a linear relationship exists between the 
inverse brain water content and the longitudinal relaxation rate (1/T1) in human brain (11). 
These findings suggest that the longitudinal signal decay of brain tissue, which is observed to 
be a single exponential, arises from a fast exchange between free and hydration water 
compartments (12). Thus, the measured T1 time is a weighted average of the free (long T1) and 
bound (short T1) water phases (13). Quantitative maps of T1 may therefore provide valuable 
information on the spatial distribution of brain water abnormalities associated with intracranial 
tumors (4). 
A recent study by De Belder et al. compared meningioma (N = 20) and HGG (N = 15) 
using DT-MRI (5). These investigators found that FA values were significantly higher and 
<D> values significantly lower for meningioma and associated edema than for HGG, 
indicating the higher degree of cellular organization in meningioma compared with HGG. 
These findings are in agreement with those reported by Bastin et al. who found that FA values 
were significantly higher in meningioma (N = 3) than HGG (N = 3), while D values were 
significantly lower, findings that were repeated when comparing edema values between patient 
groups (4). In addition, this study revealed that T1 values were significantly lower in 
meningioma compared with HGG indicating less disturbance in brain water homeostasis. A 
further study by Garcia et al. measured differences in MTR values between glioblastoma 
multiforme (N = 9) and meningioma (N = 4), with the former showing the most abnormal and 
the latter the least abnormal MTR values compared with normal-appearing tissue (6). These 
studies demonstrate the potential for quantitative imaging biomarkers to provide useful 
information about tumor properties, and possibly differentiate between different tumor types. 
However, in order to achieve this potential further data encompassing other tumor types is 
required. 
 The objective of the current study was to investigate whether multiple imaging 
biomarkers provided by DT-, MT- and T1-mapping MRI were significantly different in 
meningioma compared with LGG using region-of-interest (ROI) analysis. Due to the 
differences in pathology between these two tumor types, we hypothesized that each biomarker 
would indicate a higher microstructural integrity in meningioma compared with LGG for 
tumor, edema and ipsilateral white matter compared with contralateral normal-appearing white 
matter (NAWM). 
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2. Materials and Methods 
2.1 Subjects 
Nine patients with meningioma (5 male; mean age 49.8 ± 10.5 (range 35 – 64) years) and 11 
with LGG (5 male; mean age 49.1 ± 11.7 (range 30 – 63) years) were identified by clinical and 
radiological assessment with subsequent confirmation of tumor type by histology. None of 
these subjects had begun corticosteroid treatment, radiotherapy or chemotherapy at the time of 
MRI, and there was no evidence of neurological disorders other than the primary neoplasm 
from the radiological data. The local ethics committee approved the study and informed 
consent was obtained from each patient. 
 
2.2 MRI acquisition 
All MRI data were obtained using a GE Signa Horizon HDxt 1.5 T clinical scanner (General 
Electric, Milwaukee, WI, USA) using a self-shielding gradient set with maximum gradient 
strength of 33 mT/m, and an 8-channel phased-array head coil. The examination comprised the 
following whole brain sequences acquired with contiguous axial slice locations: standard 
structural T2W MRI, two T1-weighted fast-spoiled gradient echo (FSPGR) scans with 2 and 
12
o
 flip angles for quantitative T1-mapping, two standard spin echo sequences acquired with 
and without a magnetization transfer pulse applied 1 kHz from the water resonance frequency 
for MT-MRI, and finally a DT-MRI protocol consisting of seven T2W and sets of diffusion-
weighted (b = 1000 s/mm
2
) single-shot spin-echo echo-planar imaging (EPI) volumes acquired 
with diffusion gradients applied in 64 non-collinear directions (14). The acquisition took 
approximately 50 minutes. The acquisition parameters for the structural T2W, DT-, MT- and 
T1-mapping MRI protocols, i.e. field-of-view (256  256 mm in all cases), imaging matrix (128 
 128 for DT-MRI, and 256  256 for the other sequences), slice thickness and location (72  2 
mm in all cases), were chosen to allow easier co-registration between scans so that the imaging 
biomarkers could be accurately measured within ROI in the EPI and non-EPI based sequences. 
 
2.3 Image processing 
MRI data were converted from DICOM (http://dicom.nema.org) to NIfTI-1 
(http://nifti.nimh.nih.gov/nifti-1) format, and pre-processed using FSL tools 
(http://www.fmrib.ox.ac.uk/fsl). The DT-MRI data were pre-processed to extract the brain 
(15), and remove bulk patient motion and eddy current induced artifacts by registering the 
diffusion-weighted to the first T2W EPI volume for each subject (16). From these MRI data, 
D, AX, RAD and FA volumes were generated for every subject using DTIFIT. 
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Quantitative maps of T1 were obtained by registering the 2 and 12
o
 FSPGR sequences 
to the T2W structural scan using FLIRT, with T1 being determined from 
,                          (1) 
where TR is the repetition time (= 6 ms), 1 = 2°, 2 = 12°, SR = S1 / S2, and S1 and S2 the 
signal intensity values in each voxel for 1 and 2 respectively (17). Similarly maps of MTR 
were obtained by registering the two component spin echo sequences to the T2W structural 
volume and calculating this biomarker on a voxel-by-voxel basis using 
 ,                                    (2) 
where Ms and M0 represent signal intensities with and without the magnetization transfer pulse 
(10). 
Using Analyze11.0
TM
 software (Mayo Clinic, KS, USA; 
http://www.analyzedirect.com) and the standard structural and EPI-based T2W sequences, one 
investigator (RJP) conducted manual ROI segmentation of brain tumor and edema in each 
patient. Firstly, ROI were carefully drawn round tumor and edema in each slice where they 
were visible on the structural T2W scan. These regions were then masked off, and FSL’s FAST 
(18) applied to identify regions of NAWM in the ipsi- and contralateral hemispheres. To 
provide measurements of the imaging biomarkers in the different tissue types, these masks 
were then applied directly to the MTR and T1 volumes without further registration steps, and to 
the D, FA, AX and RAD volumes by applying the non-linear warp field obtained by non-
linear registration (FSL’s FNIRT) of the structural T2W volume to the DT-MRI T2W EPI 
volume. 
 
2.4 Statistics 
In addition to presenting mean values of D, FA, AX, RAD, MTR and T1 in each tissue type, 
each imaging biomarker measurement was normalized by the corresponding NAWM values in 
the contralateral hemisphere, i.e. tumor/contralateral NAWM, edema/contralateral NAWM and 
ipsilateral NAWM/contralateral NAWM, to allow each patient to act as their own control. T-
tests were then used to compare these mean and ratio values between meningioma and LGG in 
the various tissue types. Statistical analyses were carried out using GraphPadPrism v5.0 
(GraphPad Software Inc, CA, USA; http://www.graphpad.com) for MacOSX. Statistical 
significance was set at p < 0.05, with all data presented as mean ± SD (range). 
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3. Results 
Six patients with meningioma and six with LGG had edema present on structural T2W MRI; 
two patients with LGG were excluded since tumor could not be sufficiently delineated from 
surrounding edema. 
 Figures 1 and 2 show examples of ROI segmentations and biomarker maps for two 
representative patients with meningioma and LGG. For both tumor types, note the reduced 
MTR and FA, and elevated T1, D, AX and RAD in tumor and edema compared with 
surrounding normal-appearing tissue. 
 
3.1 Mean imaging biomarker values 
Table 1 shows mean values for all imaging biomarkers in tumor, edema, ipsi- and contralateral 
white matter. For tumor tissue, meningioma had higher MTR (43.67 ± 3.28 (range 37.77 – 
47.93) versus 39.02 ± 4.04 (range 32.29 – 43.43) %; p < 0.02) and FA (0.19 ± 0.04 (range 0.12 
– 0.25) versus 0.11 ± 0.02  (range 0.08 – 0.16); p << 0.001) values than LGG, and significantly 
lower values of T1 (1.62 ± 0.13 (range 1.40 – 1.82) versus 2.01 ± 0.45 (range 1.56 – 2.84) s; p 
= 0.02), D (856 ± 130 (range 553 – 969) versus 1367 ± 168 (range 1179 – 1687) × 10-6 
mm
2
/s; p << 0.001), AX (1006 ± 149 (range 677 – 1151) versus 1511 ± 166 (range 1305 – 
1816) × 10
-6
 mm
2
/s; p << 0.001) and RAD (781 ± 123 (range 491 – 878) versus 1294 ± 171 
(range 1116 – 1623) × 10-6 mm2/s; p << 0.001). For edematous brain, there were no significant 
differences in MTR, D, AX and RAD between meningioma and LGG. However, differences 
in T1 (1.31 ± 0.19 (range 1.08 – 1.56) versus 1.68 ± 0.35 (range 1.31 – 2.23) s; p < 0.05) and 
FA (0.24 ± 0.05 (range 0.20 – 0.33) versus 0.15 ± 0.02 (range 0.12 – 0.17); p < 0.002) were 
significant. For both ipsi- and contralateral white matter, there was no significant difference in 
any imaging biomarker between tumor pathologies.  
 
3.2 Imaging biomarker values relative to contralateral normal-appearing white matter 
The ratios for all imaging biomarker measurements in tumor, edema and ipsilateral NAWM 
relative to contralateral NAWM are summarized in Table 2 and Figure 3. Meningioma MTR 
was significantly higher than that of LGG for tumor (0.79 ± 0.05 (range 0.72 – 0.86) versus 
0.69 ± 0.07 (range 0.58 – 0.76); p = 0.002), but not for edema or ipsilateral white matter. 
Meningioma T1 was significantly lower than that of LGG for both tumor (1.61 ± 0.12 (range 
1.38 – 1.78) versus 1.91 ± 0.40 (range 1.57 – 2.89); p < 0.05) and edema (1.36 ± 0.22 (range 
1.01 – 1.63) versus 1.62 ± 0.37 (range 1.26 – 2.27); p << 0.001). Ipsilateral white matter 
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showed no significant difference in either MTR or T1 relative to contralateral NAWM between 
tumor pathologies. 
For tumor tissue, D (1.22 ± 0.18 (range 0.79 – 1.38) versus 1.92 ± 0.31 (range 1.48 – 
2.41); p << 0.001), AX (1.12 ± 0.17 (range 0.74 – 1.27) versus 1.67 ± 0.23 (range 1.36 – 2.06); 
p << 0.001) and RAD (1.29 ± 0.21 (range 0.84 – 1.55) versus 2.10 ± 0.37 (range 1.57 – 2.66); p 
<< 0.001) were all significantly lower in meningioma than LGG. FA was significantly higher 
in meningioma compared with LGG (0.71 ± 0.19 (range 0.36 – 0.94) versus 0.43 ± 0.11 (range 
0.31 – 0.61); p < 0.002) in tumor tissue. Edema ratios were not significantly different except 
for FA where meningioma was significantly higher than LGG (0.90 ± 0.31 (range 0.60 – 1.49) 
versus 0.58 ± 0.09 (range 0.49 – 0.72); p < 0.05). Ipsilateral white matter showed no significant 
difference in any water diffusion parameter relative to contralateral NAWM between tumor 
pathologies. 
 
4. Discussion 
We employed multiple DT-, MT- and T1-mapping MRI biomarkers to characterize differences 
in imaging signatures between tumor, edema, and ipsilateral and contralateral white matter in 
patients with meningioma and LGG. In summary, we found significant differences in each 
parameter between meningioma and LGG tumor tissue, with the former having values closer to 
contralateral NAWM, suggesting that the organization of tissue is greater in meningioma than 
LGG. However, only T1 and FA ratios differed significantly between edema found in subjects 
with meningioma and LGG, both of which indicate a higher organization of tissue in the edema 
of meningioma. However, the small sample size of our study (N = 6 for both groups) may have 
resulted in failure to detect significant differences in the other biomarkers in edematous tissue. 
No differences were detected in any parameters in the ipsilateral white matter between 
meningioma and LGG. No parameter identified a difference between ipsilateral and 
contralateral NAWM in either tumor pathology. 
Our findings demonstrate that these multimodal MRI biomarkers differ significantly 
between meningioma and LGG in tumor tissue. Although these tumors are not often mistaken 
for one another on conventional diagnostic imaging (e.g. T2W MRI), our study supports the 
idea put forward by other investigators that imaging signatures may allow objective prediction 
of pathology (5,19). Mean T1 values were significantly higher and FA values were significantly 
lower in the edema of LGG compared to that of meningioma, suggesting a greater disruption of 
surrounding white matter architecture. This finding is in concordance with the infiltrative 
nature of glioma edema, such that the actual tumor margin is often found microscopically 
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beyond that observed on structural T2W MRI (19). Meningiomas are instead postulated to 
displace surrounding white matter tracts and tend to give rise to ‘pure vasogenic’ edema.  
Given differences in patient populations and acquisition protocols, our results are 
generally concordant with similar studies that have measured differences between quantitative 
imaging biomarkers in cerebral tumors. For meningioma, our mean D values for tumor (856 
± 130 × 10
-6
 mm
2
/s) and edema (1146 ± 152 × 10
-6
 mm
2
/s) are close to those reported by 
Bastin et al. (907 ± 92 and 1316 ± 191 × 10
-6
 mm
2
/s respectively) (4). Similarly, our mean FA 
values for meningioma (0.19 ± 0.04) and associated edema (0.24 ± 0.05) are close to those 
reported by De Belder et al. (0.27 ± 0.07 and 0.18 ± 0.12 respectively) (5) and Bastin et al. 
(0.22 ± 0.06 and 0.22 ± 0.07 respectively) (4). For T1, our mean values for meningioma (1.62 ± 
0.13 s) and edema (1.31 ± 0.19 s) are also fairly close to those in Bastin et al. (1.29 ± 0.08 and 
1.21 ± 0.14 s respectively). For LGG, De Belder et al. report FA values in HGG (0.17 ± 0.04) 
that are slightly higher than those we find in LGG (0.11 ± 0.02), which does not fit with the 
hypothesis that as glioma grade increases so does the disruption to cellular organization. 
Conversely for edematous brain, our FA values for LGG (0.15 ± 0.02) are higher than those 
reported by De Belder et al. for HGG (0.12 ± 0.04) which does agree with LGG producing a 
more marked effect on surrounding tissue. 
In addition to DT-, MT- and T1-mapping MRI, there are several other MR modalities 
that provide biomarkers that are useful in characterizing meningioma and glioma. For example, 
dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI provide 
metrics of tissue permeability and perfusion that can describe the different vascular properties 
of these two common tumor types, their grade, response to treatment and prognosis (17,20-23). 
Meningiomas are often highly vascular without a blood-brain barrier, while gliomas have 
varying degrees of vascularity and blood-brain barrier disruption depending on grade, 
characteristics that can potentially allow their differentiation (20). Proton MR spectroscopy 
(
1
H-MRS), both long and short echo time, has also been used to characterize tumor type and 
provide insights into tumor metabolism; see Horská and Barker (24) for a review. 
1
H-MRS 
findings in cerebral tumors typically show reduced N-acetylaspartate and creatine, and elevated 
choline. However, one study also found that 21 of 23 meningiomas imaged had elevated 
alanine signals (1.5 T), regardless of typical or atypical type (25), while another reported that 
17 meningioma cases showed a peak at 3.8 ppm (3 T), perhaps corresponding to glutamate, 
that was not evident in either 24 HGG or nine metastasis cases (26). 
A limitation of our study, beyond the small sample size, was the difficulty encountered 
with manual segmentation of the cerebral tumors. This problem was particularly pronounced in 
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LGG where the demarcation of tumor, edema and parenchyma was sometimes unclear and 
therefore subjective on ROI measurement. (MRI Intravenous contrast agents often aid 
differentiation of the different tissue types, but was not used here due to ethical considerations.) 
Performing the study at higher field strength (3T) may have helped reduce this problem (27). 
Additionally we were not able to compare our segmentation margins directly to pathology, as 
performed in another study (28). A number of methods have been designed to enable automatic 
or semi-automatic segmentation of brain tumors. For example, Kaus et al., report a method 
using gradient-echo MRI that allows automated segmentation of meningioma and LGG which 
is faster than manual segmentation (5-10 minutes versus 3-5 hours) and more reproducible 
between users (29). However, while this and similar automatic methods may provide rapid and 
reproducible segmentations, the results may still not be accurate with regard to the underlying 
pathology. 
We were not able to identify differences in any biomarker in the ipsilateral white matter 
between meningioma and LGG suggestive of increased tumor infiltration in the latter. 
However, our method may not have been sensitive enough to measure such differences given 
that we measured the average value for the entire hemisphere in which the tumor was present. 
A more sensitive approach may have been achieved by using standardized ROI placement 
closer to the tumor margin. However, a study by Price et al. used smaller ROI to measure 
‘local’ ipsilateral white matter structure and did not report a significant difference between this 
value and contralateral NAWM in cases of non-HGG and meningioma (30). 
Another limitation of our work is that we have not separately analyzed the subtypes of 
meningioma or LGG. Previous work has shown an inverse correlation between D and the 
grade of astrocytic tumors (31), while the range of FA values are greater in HGG than LGG 
(32). In addition, both diffusion-weighted and DT-MRI have been employed to show 
differences in diffusion measurements between meningioma of different histopathology 
(33,34). 
Finally, T1 values were measured using a clinically optimized two flip angle method, 
also known as ‘DESPOT1’ (17,35). This approach has the advantage of generating T1 maps 
with whole-brain coverage and adequate signal-to-noise ratio within a short acquisition time. 
However, the resulting T1 values tend to be larger than those obtained using standard inversion 
recovery methods (36), while flip angle variations across the brain caused by radiofrequency 
field inhomogeneities also introduce errors. At 1.5 T and using a radiofrequency transmit 
volume coil, such flip angle variations should be minimized and be reasonably consistent 
within the cohort. 
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From our study findings and limitations, a number of recommendations for further 
research can be made. Firstly, it may be suggested that using a combination of multimodal 
structural- and water diffusion tensor-based biomarkers may allow quantitative and perhaps 
computer-automated distinction between tumors of different pathology. Other investigators 
have suggested that a radiological method may even be able to replace invasive biopsy in the 
diagnosis of brain tumors. For example, a study by Byrnes et al. measured D and FA in tumor 
and edema and found that imaging profiles alone were able to identify correctly glioblastoma 
in 69%, meningioma in 75% and metastasis in 100% of cases (37). In another study, the same 
group was able to distinguish correctly glioblastoma (87.5%) and cerebral metastases (83.3%) 
using just D and FA parameters (38). However, these studies did not include other tumor 
types such as LGG. With these and our findings in mind, it may therefore be possible to devise 
a quantitative index of imaging signatures of cerebral tumors. Such an index may support non-
invasive and accurate prediction of tumor pathology. Secondly, there is a need to develop 
accurate and reliable methods to segment cerebral tumors, either using manual or more 
sophisticated automated methods. Finally, much larger studies of a wide range of patients are 
now required to develop further the use of quantitative MRI in brain tumor research. 
 
5. Conclusions 
These results suggest that DT-, MT- and T1-mapping MRI biomarkers are significantly 
different between edema, and in particular tumor tissue, in meningioma and LGG; ratios to 
contralateral NAWM show that the organization of tissue in the edema of meningioma is closer 
to normality than LGG. However, our results require validation in studies with larger samples. 
Nevertheless, by using multiple quantitative MRI biomarkers it may be possible to employ 
neuroimaging to characterize tumor pathology accurately and non-invasively. 
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Figure 1: Maps of (a, b) T2-weighted signal intensity, (c) magnetization transfer ratio (MTR; 
%), (d) longitudinal relaxation time (T1; s), (e) mean (D; × 10
-6
 mm
2
/s), (f) axial (AX; × 10
-6
 
mm
2
/s) and (g) radial (RAD; × 10
-6
 mm
2
/s) diffusivity, and (h) fractional anisotropy (FA) at the 
level of the lateral ventricles for a 47 year old male patient with a left hemisphere meningioma. 
Regions of tumor and edema are indicated in red and blue in (b). All images are displayed in 
radiological convention.  
 
Figure 2: Maps of (a, b) T2-weighted signal intensity, (c) magnetization transfer ratio (MTR; 
%), (d) longitudinal relaxation time (T1; s), (e) mean (D; × 10
-6
 mm
2
/s), (f) axial (AX; × 10
-6
 
mm
2
/s) and (g) radial (RAD; × 10
-6
 mm
2
/s) diffusivity, and (h) fractional anisotropy (FA) at the 
level of the lateral ventricles for a 33 year old female patient with a right hemisphere low-grade 
glioma. Regions of tumor and edema are indicated in red and blue in (b). All images are 
displayed in radiological convention. 
 
Figure 3: Bar plots showing differences between meningioma and low-grade glioma (LGG) 
relative to contralateral normal-appearing white matter (NAWM) for both (a) tumor and (b) 
edema for magnetization transfer ratio (MTR), longitudinal relaxation time (T1), mean (D), 
axial (AX) and radial (RAD) diffusivity, and fractional anisotropy (FA). The asterisk indicates 
a significant difference between tumor types at the p < 0.05 level. 
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Table 1. Mean imaging biomarker values for meningioma and low-grade glioma (LGG). 
 N MTR (%) T1 (s) D ( 
10
-6
 
mm
2
/s) 
AX ( 
10
-6
 
mm
2
/s) 
RAD ( 
10
-6
 
mm
2
/s) 
FA 
Tumor 
 Meningio
ma 
9 43.67 ± 
3.28* 
1.62 ± 
0.13* 
856 ± 
130* 
1006 ± 
149* 
781 ± 
123* 
0.19 ± 
0.04* 
 LGG  9 39.02 ± 
4.04* 
2.01 ± 
0.45* 
1367 ± 
168* 
1511 ± 
166* 
1294 ± 
171* 
0.11 ± 
0.02* 
 p-value  < 0.02 0.02 << 
0.001 
<< 
0.001 
<< 
0.001 
<< 
0.001 
Edema 
 Meningio
ma 
6 47.23 ± 4.16 1.31 ± 
0.19* 
1146 ± 
152 
1421 ± 
140 
1008 ± 
159 
0.24 ± 
0.05* 
 LGG 6 45.36 ± 3.95 1.68 ± 
0.35* 
1216 ± 
154 
1391 ± 
149 
1129 ± 
156 
0.15 ± 
0.02* 
 p-value  0.44 < 0.05 0.44 0.73 0.21 < 0.002 
Ipsilateral normal-appearing white matter 
 Meningio
ma 
9 54.20 ± 2.98 1.06 ± 
0.10 
716 ± 
37 
920 ± 
24 
613 ± 
48 
0.28 ± 
0.04 
 LGG 9 55.83 ± 0.79 1.08 ± 
0.17 
734 ± 
61 
926 ± 
47 
637 ± 
69 
0.26 ± 
0.04 
 p-value  0.13 0.77 0.46 0.76 0.40 0.31 
Contralateral normal-appearing white matter 
 Meningio
ma 
9 55.23 ± 2.23 1.01 ± 
0.08 
704 ± 
39 
901 ± 
29 
606 ± 
49 
0.27 ± 
0.04 
 LGG 9 56.45 ± 0.68 1.06 ± 
0.17 
719 ± 
57 
909 ± 
43 
623 ± 
65 
0.26 ± 
0.04 
p-value  0.14 0.46 0.53 0.65 0.52 0.59 
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MTR = magnetization transfer ratio; T1 = longitudinal relaxation time; D = mean diffusivity; AX = 
axial diffusivity; RAD = radial diffusivity; FA = fractional anisotropy. p-value given for difference 
between meningioma and LGG in each ROI. *indicates statistical significance (p < 0.05). 
Table 2. Ratio of each biomarker value to contralateral normal-appearing white matter for 
meningioma and low-grade glioma (LGG). 
 N MTR T1  D AX RAD FA 
Tumor 
Meningioma 9 0.79 ± 
0.05* 
1.61 ± 
0.12* 
1.22 ± 
0.18* 
1.12 ± 
0.17* 
1.29 ± 
0.21* 
0.71 ± 
0.19* 
LGG 9 0.69 ± 
0.07* 
1.91 ± 
0.40* 
1.92 ± 
0.31* 
1.67 ± 
0.23* 
2.10 ± 
0.37* 
0.43 ± 
0.11* 
p-value  0.002 < 0.05 << 0.001 << 0.001  << 0.001 < 0.002 
Edema 
Meningioma 6 0.86 ± 
0.051 
1.36 ± 
0.22* 
1.64 ± 
0.26 
1.56 ± 
0.16 
1.70 ± 
0.34 
0.90 ± 
0.31* 
LGG 6 0.80 ± 
0.067 
1.62 ± 
0.37* 
1.72 ± 
0.02 
1.55 ± 
0.18 
1.85 ± 
0.28 
0.58 ± 
0.09* 
p-value  0.088 << 0.001 0.56 0.95 0.43 < 0.05 
Ipsilateral normal-appearing white matter 
Meningioma 9 0.98 ± 0.02 1.05 ± 0.07 1.02 ± 
0.03 
1.02 ± 
0.03 
1.01 ± 
0.04 
1.04 ± 
0.09 
LGG 9 0.99 ± 0.01 1.02 ± 0.03 1.02 ± 
0.03 
1.02 ± 
0.02 
1.02 ± 
0.03 
1.00 ± 
0.03 
p-value  0.32 0.24 0.79 0.77 0.60 0.22 
MTR = magnetization transfer ratio; T1 = longitudinal relaxation time; D = mean diffusivity; AX = 
axial diffusivity; RAD = radial diffusivity; FA = fractional anisotropy. p-value given for difference 
between meningioma and LGG in each ROI. *indicates statistical significance (p < 0.05). 
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